KIM
COCH icon

Karpus Investment Management’s Envoy Medical COCH Stock Holding History

Karpus Investment Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-964,920
Closed -$9.67M – 383
2022
Q4 		$9.67M Buy
964,920
+906,900
+1,563% +$9.02M 0.33% 69
2022
Q3 		$570K Hold
58,020
– – 0.02% 383
2022
Q2 		$568K Hold
58,020
– – 0.02% 385
2022
Q1 		$567K Hold
58,020
– – 0.02% 333
2021
Q4 		$565K Sell
58,020
-15,400
-21% -$150K 0.02% 297
2021
Q3 		$713K Hold
73,420
– – 0.02% 231
2021
Q2 		$715K Buy
+73,420
New +$713K 0.02% 224

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Karpus Investment Management's COCH Position: Q1 2023 in Review

Karpus Investment Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 964,920 shares — an estimated $9.67M sold.

Karpus Investment Management first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $9.67M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Karpus Investment Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Karpus Investment Management sold 964,920 Envoy Medical shares in Q1 2023, an estimated $9.67M.
  • Karpus Investment Management first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Karpus Investment Management's Envoy Medical position peaked at $9.67M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Karpus Investment Management's 13F filing for Q1 2023, filed 11 May 2023.